The 1Florida Alzheimer’s Disease Research Center (1Florida ADRC) is working toward a world where Alzheimer’s disease and related dementias are detected and addressed at their earliest biological stages. Through rigorous research and evidence-based clinical approaches, we bring together leading institutions under a unified scientific framework — translating complex biomarker and phenotypic data into meaningful advances for all communities affected by these diseases.
Science With Purpose
The 1Florida ADRC serves as a vital foundation supporting the broader national Alzheimer’s research mission. We are dedicated to advancing the understanding, diagnosis, and treatment of Alzheimer’s disease and related dementias (AD/ADRD) — working to turn scientific discovery into real-world impact for patients and families across Florida and beyond.
Be Part of the Breakthrough
You don’t have to be a scientist to advance Alzheimer’s research. Whether you’re experiencing memory concerns or simply aging well, your participation helps us understand the full picture of this disease — and brings us closer to answers that benefit families for generations to come.
Accelerate Your Research
The 1Florida ADRC gives investigators access to a rich repository of longitudinal data, biospecimens, imaging, and open-source tools — including NACCulator and DxSter. Submit a data or biospecimen request and our team will guide you through the rest.
Fund the Future of Memory
Alzheimer’s disease affects millions of families — and the path to a cure runs through research. Your gift directly supports the scientists, studies, and clinical evaluations that are driving new discoveries at the 1Florida ADRC. Every contribution, at any level, helps keep this vital work moving forward.
Stay in the Know
From research milestones and clinical trial updates to community events and educational resources, there’s always something happening at the 1Florida ADRC. Follow along and be the first to hear about breakthroughs, opportunities to get involved, and news that matters to patients, families, and the broader Alzheimer’s community.
You must be logged in to post a comment.